Clinical Trial Update: Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy of Ramdicivir and Baricitinib for severe COVID-19, including COVID-19 ARDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Due to COVID-19

Drugs mentioned

• Baricitinib (baricitinib)
• Ramdicivir

Snippet

Sponsor: M Abdur Rahim Medical College and Hospital | Conditions: Covid19, Covid-19 ARDS | Phase 3 | Status: UNKNOWN